Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Geovax Labs
(NQ:
GOVX
)
6.880
+3.530 (+105.37%)
Streaming Delayed Price
Updated: 1:46 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
70,998,199
Open
3.640
Bid (Size)
6.850 (1)
Ask (Size)
6.880 (5)
Prev. Close
3.350
Today's Range
3.640 - 7.070
52wk Range
1.090 - 9.750
Shares Outstanding
2,172,309
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?
August 15, 2024
Several healthcare stocks associated with mpox are seeing increased attention Thursday after the World Health Organization declared a public health emergency in response to an mpox outbreak in Africa.
Via
Benzinga
GeoVax to Present at the Emerging Growth Conference on August 21, 2024
August 15, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
Performance
YTD
+23.96%
+23.96%
1 Month
+132.43%
+132.43%
3 Month
+295.40%
+295.40%
6 Month
+177.42%
+177.42%
1 Year
-11.52%
-11.52%
More News
Read More
WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak
August 14, 2024
Via
Benzinga
GeoVax, SIGA Technologies Shares Soar After WHO Declares Mpox A Global Health Emergency
August 14, 2024
Via
Benzinga
GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board
August 08, 2024
Via
NewMediaWire
Exposures
COVID-19
GeoVax (GOVX) Stock Pops Ahead of July 18 Catalyst
July 16, 2024
Via
InvestorPlace
GeoVax Provides First Half 2024 Business Update
July 09, 2024
Via
NewMediaWire
(GOVX) - Analyzing Geovax Labs's Short Interest
July 02, 2024
Via
Benzinga
GOVX Stock Earnings: Geovax Labs Beats EPS for Q2 2024
August 06, 2024
Via
InvestorPlace
GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update
August 06, 2024
Via
NewMediaWire
Exposures
COVID-19
Update: GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee Review
July 31, 2024
Via
NewMediaWire
GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee Review
July 31, 2024
Via
NewMediaWire
GeoVax to Report Second Quarter 2024 Financial Results and Provide Corporate Update on August 6, 2024
July 30, 2024
Via
NewMediaWire
Why Is GeoVax (GOVX) Stock Up 110% Today?
June 27, 2024
Via
InvestorPlace
Exposures
COVID-19
GeoVax to Present at the Emerging Growth Conference on July 18, 2024
July 16, 2024
Via
NewMediaWire
Exposures
COVID-19
GeoVax to Present at the Emerging Growth Conference on July 18, 2024
July 16, 2024
Via
TheNewswire.com
Exposures
COVID-19
GeoVax to Raise Approximately $3.1 Million of Gross Proceeds in Offering Priced At-the-Market
July 11, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
GeoVax to Raise Approximately $3.1 Million of Gross Proceeds in Offering Priced At-the-Market
July 11, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Why GeoVax Labs Stock Is Moving Higher Thursday
June 27, 2024
Via
Benzinga
Exposures
COVID-19
GeoVax Partners with Allucent to Conduct Phase 2b Clinical Study of Next-Generation COVID-19 Vaccine Candidate with Funding from BARDA
June 27, 2024
Via
NewMediaWire
Exposures
COVID-19
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 27, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
June 26, 2024
Via
InvestorPlace
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
June 20, 2024
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 20, 2024
Via
Benzinga
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
June 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.